đź“Š Evidence-Based Reference
ai segmentation
Varian Medical Systems
Summary: AI segmentation by Varian Medical Systems is an FDA-cleared device used for automated image segmentation in clinical settings. Key evidence highlights its application in improving diagnostic accuracy in various medical imaging modalities.
FDA Clearance Information
Pathway
510K
Number
K203469 ↗
Decision Date
April 19, 2021
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
The AI segmentation device by Varian Medical Systems was cleared via the FDA 510(k) pathway on April 19, 2021. It is classified as a Class 2 device under product code MUJ.
What It Is
The AI segmentation device is designed to automate the segmentation of medical images, enhancing the accuracy and efficiency of image interpretation. It is intended for use in various clinical imaging applications, including MRI and ultrasound.
Clinical Applications
Common clinical scenarios for this device include segmentation of glioblastoma on MRI, foreign body detection in ultrasound, and dental imaging for pulp cavity structures. It aids clinicians in precise image analysis and decision-making.
Evidence Summary
The literature includes 14 studies, encompassing various study types such as RCTs and case series, published between 2024 and 2025. These studies evaluate the device's performance in different clinical contexts.
Reported Outcomes
Published studies report that the AI segmentation device improves the accuracy of image segmentation in medical imaging, such as glioblastoma MRI and dental CBCT scans. It enhances diagnostic precision and supports clinical decision-making.
Safety Profile
Reported complications include minimal errors in segmentation that require manual correction. Overall, the device is considered safe with no significant adverse events reported in the studies.
Evidence Limitations
Evidence gaps include a need for larger, diverse population studies to validate findings across different clinical settings. Some studies report limited sample sizes and potential biases in manual correction processes.
Frequently Asked Questions
What are the clinical indications for AI segmentation?
The device is indicated for use in automated segmentation of medical images, including MRI, ultrasound, and CBCT, to improve diagnostic accuracy.
What outcomes have been reported in clinical studies?
Studies report improved segmentation accuracy and diagnostic precision in imaging modalities such as MRI and CBCT.
What complications have been reported?
Safety data indicate minimal segmentation errors requiring manual correction, with no significant adverse events reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.